Published in J Hum Hypertens on February 01, 1999
Reduction in finger blood flow induced by hand-transmitted vibration: effect of hand elevation. Int Arch Occup Environ Health (2015) 0.79
Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement. J Am Soc Hypertens (2016) 0.79
Challenges in standardization of blood pressure measurement at the population level. BMC Med Res Methodol (2015) 0.78
Standardising blood pressure measurement in everyday practice: what's the gold standard? J Hum Hypertens (1999) 0.78
Knowledge of accurate blood pressure measurement procedures in chiropractic students. J Chiropr Educ (2013) 0.75
Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review. J Hypertens (2016) 0.75
Office blood pressure measurement practices among community health providers (medical and paramedical) in northern district of India. Indian Heart J (2014) 0.75
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab (2001) 1.91
Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol (1996) 1.85
Both body and arm position significantly influence blood pressure measurement. J Hum Hypertens (2003) 1.73
A template for improved prevention and control of cardiovascular disease in sub-Saharan Africa. Health Policy Plan (2001) 1.69
Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med (1999) 1.65
Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med (1995) 1.64
Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans. J Physiol (2007) 1.61
The effects of caffeine on the postprandial fall of blood pressure in the elderly. Age Ageing (1988) 1.54
Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption. Eur J Clin Invest (1999) 1.53
Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects. Diabetes Care (1998) 1.52
Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communities. J Hum Hypertens (2000) 1.46
Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J (2001) 1.42
Comparison of two indices for forearm noradrenaline release in humans. Clin Sci (Lond) (2000) 1.42
Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon. Clin Sci (Lond) (1991) 1.40
The effect of caffeine on renal vein renin concentration in patients with renal arterial disease. Am J Hypertens (1991) 1.40
Dynamic vessel wall properties and their reproducibility in subjects with increased cardiovascular risk. J Hum Hypertens (1998) 1.40
Venous reflux has a limited effect on calf muscle pump dysfunction in post-thrombotic patients. Clin Sci (Lond) (2000) 1.39
[Von Hippel-Lindau disease]. Ned Tijdschr Geneeskd (2000) 1.39
[A single blood pressure reading during check-up for hypertension leads to a change in management more often than multiple readings]. Ned Tijdschr Geneeskd (1994) 1.39
[No response to antihypertensive therapy: consider non-adherence]. Ned Tijdschr Geneeskd (2007) 1.39
[Hypertension and renal artery stenosis; a combination with a difficult diagnosis and treatment]. Ned Tijdschr Geneeskd (1996) 1.39
The role of the alpha-adrenergic receptor in the leg vasoconstrictor response to orthostatic stress. Acta Physiol (Oxf) (2008) 1.39
Withdrawal of antihypertensive drugs in selected patients. Lancet (1994) 1.39
Routine intracoronary beta-irradiation. Acute and one year outcome in patients at high risk for recurrence of stenosis. Eur Heart J (2002) 1.38
[Diagnosis and therapy of hypertension with renal artery stenosis]. Ned Tijdschr Geneeskd (1996) 1.38
Sodium-blood pressure interrelationship in pregnancy. J Hum Hypertens (1999) 1.38
[Compliance with therapy: determining factors and possibilities for improvement]. Ned Tijdschr Geneeskd (1994) 1.37
Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Intern Med (1994) 1.29
Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia (1998) 1.20
The complete amino-acid sequence of the sweet protein thaumatin I. Eur J Biochem (1979) 1.19
Methotrexate modulates the kinetics of adenosine in humans in vivo. Ann Rheum Dis (2005) 1.18
Influence of non-steroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension. Br Med J (Clin Res Ed) (1984) 1.17
Orthostatic tolerance, cerebral oxygenation, and blood velocity in humans with sympathetic failure. Stroke (2000) 1.17
Baroreflex failure following radiation therapy for nasopharyngeal carcinoma. Clin Auton Res (1999) 1.16
Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension (2000) 1.14
Serum concentrations of immunoreactive calcitonin in patients with hypergastrinaemia. Digestion (1980) 1.13
Characterization of ATP-induced vasodilation in the human forearm vascular bed. Circulation (1994) 1.13
Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther (1990) 1.12
The case for case reports in the Netherlands Journal of Medicine. Neth J Med (2006) 1.10
The captopril test in the detection of renovascular disease in hypertensive patients. Arch Intern Med (1990) 1.10
Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension (1998) 1.09
Role of the wrist cuff in forearm plethysmography. Clin Sci (Lond) (1991) 1.09
[Lavage almost never indicated after an autointoxication]. Ned Tijdschr Geneeskd (2000) 1.08
Vascular adaptations to 8-week cycling training in older men. Acta Physiol (Oxf) (2007) 1.07
Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients. Diabetologia (2008) 1.07
Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension (1999) 1.06
Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1-0.2 Mb bacterial artificial chromosome array spanning chromosome arm 1p. Genes Chromosomes Cancer (2006) 1.05
Radioenzymatic assay of plasma adrenaline and noradrenaline: evidence for a catechol-O-methyltransferase (COMT) inhibiting factor associated with essential hypertension. Clin Chim Acta (1982) 1.05
Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol (1987) 1.05
Comparison of intrabrachial and finger blood pressure in healthy elderly volunteers. Am J Hypertens (1995) 1.05
Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab (1998) 1.05
Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab (2001) 1.04
Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest (2005) 1.04
Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab (1995) 1.03
Does it matter whether blood pressure measurements are taken with subjects sitting or supine? J Hypertens (1998) 1.03
Metformin improves cardiac functional recovery after ischemia in rats. Horm Metab Res (2002) 1.03
Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest (2001) 1.02
Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone (2001) 1.01
The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension. J Clin Pharmacol (1992) 1.01
Effect of decaffeinated versus regular coffee on blood pressure. A 12-week, double-blind trial. Hypertension (1989) 1.00
In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature. Br J Pharmacol (2001) 0.99
Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients. J Clin Microbiol (2000) 0.98
Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Int J Sports Med (1988) 0.98
Direct vasodilator effects of physiological hyperinsulin-aemia in human skeletal muscle. Eur J Clin Invest (1996) 0.98
Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem (1995) 0.98
MRI in patients with suspected vascular parkinsonism. Neurology (1995) 0.97
Reduced imprecision of the radioenzymatic assay of plasma catecholamines by improving the stability of the internal standards. Clin Chim Acta (1986) 0.97
Kinetics of (-)125iodocyanopindolol binding to intact human mononuclear cells. J Recept Res (1988) 0.97
Heat-induced association of beta-lactoglobulin and casein micelles. J Dairy Res (1980) 0.96
ATP-induced vasodilation in human skeletal muscle. Br J Pharmacol (2004) 0.96
Cardiovascular pharmacology of purines. Clin Sci (Lond) (1997) 0.96
Hemodynamic and humoral effects of coffee after beta 1-selective and nonselective beta-blockade. Clin Pharmacol Ther (1983) 0.96
Glomerular filtration and saturable absorption of iohexol in the rat isolated perfused kidney. Br J Pharmacol (1996) 0.95
Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience. Ann N Y Acad Sci (2006) 0.95
6-[18F]fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function--studies in normal humans. Clin Auton Res (1997) 0.95
Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia (1996) 0.94